第 1 到 51 筆結果,共 51 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2022 | Clinical Outcomes of Metastatic Breast Cancer in Patients Having Imaging Liver Pseudocirrhosis with or without Evident Varices | WEI-LI MA ; DWANG-YING CHANG ; CHING-HUNG LIN ; KAO-LANG LIU ; PO-CHIN LIANG ; HUANG-CHUN LIEN ; Hu, Chan-Chuan; Huang, Ling-Yun; Yeh, Yi-Chun; YEN-SHEN LU | The oncologist | 0 | 1 | |
2 | 2021 | The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group | El Bairi, Khalid; Haynes, Harry R; Blackley, Elizabeth; Fineberg, Susan; Shear, Jeffrey; Turner, Sophia; de Freitas, Juliana Ribeiro; Sur, Daniel; Amendola, Luis Claudio; Gharib, Masoumeh; Kallala, Amine; Arun, Indu; Azmoudeh-Ardalan, Farid; Fujimoto, Luciana; Sua, Luz F; Liu, Shi-Wei; HUANG-CHUN LIEN ; Kirtani, Pawan; Balancin, Marcelo; El Attar, Hicham; Guleria, Prerna; Yang, Wenxian; Shash, Emad; I-CHUN CHEN ; Bautista, Veronica; Do Prado Moura, Jose Fernando; Rapoport, Bernardo L; Castaneda, Carlos; Spengler, Eunice; Acosta-Haab, Gabriela; Frahm, Isabel; Sanchez, Joselyn; Castillo, Miluska; Bouchmaa, Najat; Md Zin, Reena R; Shui, Ruohong; Onyuma, Timothy; Yang, Wentao; Husain, Zaheed; Willard-Gallo, Karen; Coosemans, An; Perez, Edith A; Provenzano, Elena; Ericsson, Paula Gonzalez; Richardet, Eduardo; Mehrotra, Ravi; Sarancone, Sandra; Ehinger, Anna; Rimm, David L; Bartlett, John M S; Viale, Giuseppe; Denkert, Carsten; Hida, Akira I; Sotiriou, Christos; Loibl, Sibylle; Hewitt, Stephen M; Badve, Sunil; Symmans, William Fraser; Kim, Rim S; Pruneri, Giancarlo; Goel, Shom; Francis, Prudence A; Inurrigarro, Gloria; Yamaguchi, Rin; Garcia-Rivello, Hernan; Horlings, Hugo; Afqir, Said; Salgado, Roberto; Adams, Sylvia; Kok, Marleen; Dieci, Maria Vittoria; Michiels, Stefan; Demaria, Sandra; Loi, Sherene | NPJ breast cancer | 103 | 87 | |
3 | 2021 | Factors predicting one or two sentinel lymph nodes to be accepted for sentinel lymph node biopsy alone after neoadjuvant therapy in initially node-positive breast cancer patients | LI-WEI TSAI ; Lee, Yi-Hsuan; Chiao Lo ; HUANG-CHUN LIEN ; MING-YANG WANG ; I-SHIOW JAN ; RUOH-FANG YEN ; Hu, Fu-Chang; CHIUN-SHENG HUANG | Surgical oncology | 0 | 0 | |
4 | 2020 | Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials | Hudeček J.; Voorwerk L.; van Seijen M.; Nederlof I.; de Maaker M.; van den Berg J.; van de Vijver K.K.; Sikorska K.; Adams S.; Demaria S.; Viale G.; Hirsch F.R.; Klauschen F.; Penault-Llorca F.; Acosta Haab G.; Farshid G.; van den Eynden G.; Curigliano G.; Floris G.; Broeckx G.; Gonzalez-Ericsson, Koeppen H.; Nielsen T.O.; Haynes H.R.; McArthur H.; Joensuu H.; Olofsson H.; HUANG-CHUN LIEN ; I-CHUN CHEN ; Cree I.; Frahm I.; Brcic I.; Chan J.; Badve S.S.; Ziai J.; Brock J.; Wesseling J.; Giltnane J.; Kerner J.K.; Thagaard J.; Braybrooke J.P.; van der Laak J.A.W.M.; Lemonnier J.; Zha J.; Michiels S.; Ribeiro J.; Lennerz J.K.; Carter J.M.; Saltz J.; Hartman J.; Hainfellner J.; Quesne J.L.; Juco J.W.; Reis-Filho J.; Sanchez J.; Symmans W.F.; Sparano J.; Cucherousset J.; Araya J.C.; Adam J.; Balko J.M.; Saeger K.; Siziopikou K.; Willard-Gallo K.; Weber K.; Pogue-Geile K.L.; Sotiriou C.; Steele K.E.; Emancipator K.; AbdulJabbar K.; El Bairi K.; Blenman K.R.M.; Allison K.H.; Korski K.; Pusztai L.; Comerma L.; Buisseret L.; Rimm D.L.; Cooper L.A.D.; Shi L.; Kooreman L.F.S.; Molinero L.; Estrada M.V.; Lacroix-Triki M.; Al Bakir M.; Sebastian M.M.; van de Vijver M.; Balancin M.L.; Hewitt S.M.; Dieci M.V.; Mathieu M.-C.; Rebelatto M.C.; Piccart M.; Hanna M.G.; Goetz M.P.; Preusser M.; Khojasteh M.; Sanders M.E.; Regan M.M.; Denkert C.; Barnes M.; Christie M.; Misialek M.; Ignatiadis M.; van Bockstal M.; Castillo M.; Amgad M.; Harbeck N.; Tung N.; Laudus N.; Loibl S.; Sirtaine N.; Burchardi N.; Ternes N.; Radosevic-Robin N.; Gluz O.; Grimm O.; Nuciforo P.; Jank P.; Gonzalez-Ericsson P.; Kirtani P.; Loi S.; Jelinic P.; Watson P.H.; Savas P.; Francis P.A.; Russell P.A.; Singh R.; Kim R.S.; Pierce R.H.; Hills R.; Leon-Ferre R.; Bartlett J.M.S.; de Wind R.; Shui R.; De Clercq S.; Leung S.; Tabbarah S.; Souza S.C.; O’Toole S.; Swain S.; Dudgeon S.; Willis S.; Pruneri G.; Ely S.; Kim S.-R.; Bedri S.; Irshad S.; Liu S.-W.; Goel S.; Hendry S.; Bianchi S.; Bragança S.; Paik S.; Dillon D.A.; Wienert S.; Fox S.B.; Luen S.J.; Naber S.; Schnitt S.J.; Sua L.F.; Lakhani S.R.; Fineberg S.; Soler T.; Gevaert T.; Cheang M.C.U.; D’Alfonso T.; John T.; Sugie T.; Kurkure U.; Bossuyt V.; Manem V.; Cámara V.P.; Tong W.; Chen W.; Yang W.; Tutt A.; Tran W.T.; Wang Y.; Yuan Y.; Allory Y.; Husain Z.; Bago-Horvath Z.; International Immuno-Oncology Biomarker Working Group; Hall J.A.; Kos Z.; Salgado R.; Kok M.; Horlings H.M.; Hyytiäinen A.; Hida A.I.; Thompson A.; Lefevre A.; Lazar A.J.; Gown A.; Lo A.; Sapino A.; Madabhushi A.; Moreira A.; Richardson A.; Vingiani A.; Beck A.H.; Bellizzi A.M.; Guerrero A.; Grigoriadis A.; Ehinger A.; Garrido-Castro A.; Vincent-Salomon A.; Laenkholm A.-V.; Sharma A.; Cimino-Mathews A.; Srinivasan A.; Acs B.; Singh B.; Calhoun B.; Haibe-Kans B.; Solomon B.; Thapa B.; Nelson B.H.; Gallas B.D.; Castaneda C.; Ballesteros-Merino C.; Criscitiello C.; Boeckx C.; Colpaert C.; Quinn C.; Chennubhotla C.S.; Swanton C.; Solinas C.; Hiley C.; Drubay D.; Bethmann D.; Moore D.A.; Larsimont D.; Sabanathan D.; Peeters D.; Zardavas D.; Höflmayer D.; Johnson D.B.; Thompson E.A.; Brogi E.; Perez E.; ElGabry E.A.; Stovgaard E.S.; Blackley E.F.; Roblin E.; Reisenbichler E.; Bellolio E.; Balslev E.; Chmielik E.; Gaire F.; Andre F.; Lu F.-I.; Azmoudeh-Ardalan F.; Rojo F.; Gruosso T.; Ciompi F.; Peale F. | npj Breast Cancer | 11 | 11 | |
5 | 2020 | The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice | Gonzalez-Ericsson P.I.; Stovgaard E.S.; Sua L.F.; Reisenbichler E.; Kos Z.; Carter J.M.; Michiels S.; Le Quesne J.; Nielsen T.O.; Lænkholm A.-V.; Fox S.B.; Adam J.; Bartlett J.M.S.; Rimm D.L.; Quinn C.; Peeters D.; Dieci M.V.; Vincent-Salomon A.; Cree I.; Hida A.I.; Balko J.M.; Haynes H.R.; Frahm I.; Acosta-Haab G.; Balancin M.; Bellolio E.; Yang W.; Kirtani P.; Sugie T.; Ehinger A.; Castaneda C.A.; Kok M.; McArthur H.; Siziopikou K.; Badve S.; Fineberg S.; Gown A.; Viale G.; Schnitt S.J.; Pruneri G.; Penault-Llorca F.; Hewitt S.; Thompson E.A.; Allison K.H.; Symmans W.F.; Bellizzi A.M.; Brogi E.; Moore D.A.; Larsimont D.; Dillon D.A.; Lazar A.; HUANG-CHUN LIEN ; Goetz M.P.; Broeckx G.; El Bairi K.; Harbeck N.; Cimino-Mathews A.; Sotiriou C.; Adams S.; Liu S.-W.; Loibl S.; I-CHUN CHEN ; Lakhani S.R.; Juco J.W.; Denkert C.; Blackley E.F.; Demaria S.; Leon-Ferre R.; Gluz O.; Zardavas D.; Emancipator K.; Ely S.; Loi S.; Salgado R.; Sanders M. | Journal of Pathology | 132 | 114 | |
6 | 2020 | Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer | Kos Z.; Roblin E.; Kim R.S.; Michiels S.; Gallas B.D.; Chen W.; van de Vijver K.K.; Goel S.; Adams S.; Demaria S.; Viale G.; Moreira A.M.; Richardson A.; Vingiani A.; Bellizzi A.M.; Guerrero A.; Grigoriadis A.; Garrido-Castro A.C.; Cimino-Mathews A.; Srinivasan A.; Acs B.; Nielsen T.O.; Singh B.; Calhoun B.; Haibe-Kans B.; Solomon B.; Thapa B.; Nelson B.H.; Ballesteroes-Merino C.; Criscitiello C.; Boeckx C.; Colpaert C.; Badve S.S.; Quinn C.; Chennubhotla C.S.; Solinas C.; Drubay D.; Sabanathan D.; Peeters D.; Zardavas D.; Höflmayer D.; Johnson D.B.; Thompson E.A.; Symmans W.F.; Perez E.; ElGabry E.A.; Blackley E.F.; Reisenbichler E.; Chmielik E.; Gaire F.; Lu F.-I.; Azmoudeh-Ardalan F.; Peale F.; Hirsch F.R.; Sotiriou C.; Acosta-Haab G.; Farshid G.; Broeckx G.; Koeppen H.; Haynes H.R.; McArthur H.; Joensuu H.; Olofsson H.; Cree I.; Nederlof I.; Rimm D.L.; Frahm I.; Brcic I.; Chan J.; Ziai J.; Brock J.; Weseling J.; Giltnane J.; Lemonnier J.; Zha J.; Ribeiro J.; Hewitt S.; Lennerz J.K.; Carter J.M.; Hartman J.; Hainfellner J.; Le Quesne J.; Juco J.W.; van den Berg J.; Sanchez J.; Cucherousset J.; Adam J.; Denkert C.; Balko J.M.; Saeger K.; Siziopikou K.; Sikorska K.; Weber K.; Steele K.E.; Emancipator K.; El Bairi K.; Allison K.H.; Korski K.; Loibl S.; Buisseret L.; Shi L.; Kooreman L.F.S.; Molinero L.; Estrada M.V.; Van Seijen M.; Lacroix-Triki M.; Sebastian M.M.; Balancin M.L.; Mathieu M.-C.; Luen S.J.; van de Vijver M.; Rebelatto M.C.; Piccart M.; Goetz M.P.; Preusser M.; Khojasteh M.; Sanders M.E.; Regan M.M.; Barnes M.; Christie M.; Bartlett J.M.S.; Misialek M.; Ignatiadis M.; de Maaker M.; Van Bockstal M.; Harbeck N.; Tung N.; Laudus N.; Sirtaine N.; Burchardi N.; Ternes N.; Savas P.; Radosevic-Robin N.; Gluz O.; Grimm O.; Nuciforo P.; Jank P.; Kirtani P.; Watson P.H.; Jelinic P.; Francis P.A.; Russell P.A.; Pruneri G.; Pierce R.H.; Hills R.; Leon-Ferre R.; de Wind R.; Shui R.; Leung S.; Tabbarah S.; Souza S.C.; O’Toole S.; Swain S.; Dillon D.A.; Dudgeon S.; Willis S.; Ely S.; Bedri S.; Irshad S.; Liu S.; Hendry S.; Bianchi S.; Bragança S.; Paik S.; Cheang M.C.U.; Luz S.; Gevaert T.; d’Alfons T.; John T.; Sugie T.; Kurkure U.; Bossuyt V.; Manem V.; Cámaea V.P.; Tong W.; Tutt A.; Tran W.T.; Wang Y.; Allory Y.; Husain Z.; Bago-Horvath Z.; the International Immuno-Oncology Biomarker Working Group; Hall J.A.; Kok M.; Horlings H.M.; Madabhushi A.; van der Laak J.; Ciompi F.; Laenkholm A.-V.; Bellolio E.; Gruosso T.; Fox S.B.; Araya J.C.; Floris G.; Hudeček J.; Voorwerk L.; Beck A.H.; Kerner J.; Larsimont D.; Declercq S.; Van den Eynden G.; Pusztai L.; Ehinger A.; Yang W.; AbdulJabbar K.; Yuan Y.; Singh R.; Hiley C.; Bakir M.; Lazar A.J.; Naber S.; Wienert S.; Castillo M.; Curigliano G.; Dieci M.-V.; André F.; Swanton C.; Reis-Filho J.; Sparano J.; Balslev E.; I-CHUN CHEN ; Stovgaard E.I.S.; Pogue-Geile K.; Blenman K.R.M.; Penault-Llorca F.; Schnitt S.; Lakhani S.R.; Vincent-Salomon A.; Rojo F.; Braybrooke J.P.; Hanna M.G.; Soler-Monsó M.T.; Bethmann D.; Castaneda C.A.; Willard-Gallo K.; Sharma A.; HUANG-CHUN LIEN ; Fineberg S.; Thagaard J.; Comerma L.; Gonzalez-Ericsson P.; Brogi E.; Loi S.; Saltz J.; Klaushen F.; Cooper L.; Amgad M.; Moore D.A.; Salgado R.; Hyytiäinen A.; Hida A.I.; Thompson A.; Lefevre A.; Gown A.; Lo A.; Sapino A. | npj Breast Cancer | 87 | 90 | |
7 | 2019 | Epibulbar complex choristoma with simultaneous involvement of eyelid: a case report | Hsia Y.; HUANG-CHUN LIEN ; I-JONG WANG ; SHU-LANG LIAO ; YI-HSUAN WEI | BMC ophthalmology | 3 | 2 | |
8 | 2019 | Good staining quality ensuring the reproducibility of Ki67 assessment | Wang Y.-H.; Lai C.-R.; HUANG-CHUN LIEN ; Hsu C.-Y. | Journal of Clinical Pathology | 1 | 1 | |
9 | 2019 | Fibrillin-1, a novel TGF-beta-induced factor, is preferentially expressed in metaplastic carcinoma with spindle sarcomatous metaplasia | HUANG-CHUN LIEN ; Lee Y.-H.; Juang Y.-L.; Lu Y.-T. | Pathology | 10 | 11 | |
10 | 2018 | Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery | SUNG-HSIN KUO ; Chiao Lo ; YU-HSUAN CHEN ; HUANG-CHUN LIEN ; WEN-HUNG KUO ; Wang, Ming-Yang; Lee, Yi-Hsuan; CHIUN-SHENG HUANG | Clinical Breast Cancer | 8 | 5 | |
11 | 2018 | Increased trimethylation of histone H3K36 associates with biliary differentiation and predicts poor prognosis in resectable hepatocellular carcinoma | HUANG-CHUN LIEN ; YUNG-MING JENG ; Jhuang Y.-L.; RAY-HWANG YUAN | PLoS ONE | 13 | 13 | |
12 | 2018 | The breast graded prognostic assessment is associated with the survival outcomes in breast cancer patients receiving whole brain re-irradiation | SHIH-FAN LAI ; YU-HSUAN CHEN ; HSIANG-KUANG LIANG ; CHE-YU HSU ; HUANG-CHUN LIEN ; Lu Y.-S.; CHIUN-SHENG HUANG ; SUNG-HSIN KUO | Journal of Neuro-Oncology | 3 | 2 | |
13 | 2017 | Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer | SUNG-HSIN KUO ; Yang S.-Y.; You S.-L.; HUANG-CHUN LIEN ; CHING-HUNG LIN ; PO-HAN LIN ; CHIUN-SHENG HUANG | Oncotarget | 35 | 30 | |
14 | 2017 | Clear cell hidradenoma of the breast with MAML2 gene rearrangement | MIN-SHU HSIEH ; HUANG-CHUN LIEN ; Hua S.-F.; WEN-HUNG KUO ; Lee Y.-H. | Pathology | 11 | 9 | |
15 | 2016 | Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1–2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy | SHIH-FAN LAI ; YU-HSUAN CHEN ; WEN-HUNG KUO ; HUANG-CHUN LIEN ; Wang M.-Y.; YEN-SHEN LU ; Chiao Lo ; SUNG-HSIN KUO ; ANN-LII CHENG ; CHIUN-SHENG HUANG | Annals of Surgical Oncology | 31 | 28 | |
16 | 2016 | MED12 exon 2 mutation as a highly sensitive and specific marker in distinguishing phyllodes tumours from other spindle neoplasms of the breast | HUANG-CHUN LIEN ; CHIUN-SHENG HUANG ; YA-WEN YANG ; YUNG-MING JENG | APMIS | 11 | 8 | |
17 | 2016 | An incidental pulmonary part-solid ground-glass nodule in a patient under anticoagulant therapy | JO-YU CHEN ; HUANG-CHUN LIEN ; JIN-SHING CHEN ; YEUN-CHUNG CHANG | Thorax | 0 | 0 | |
18 | 2016 | SPOCK1 is a novel transforming growth factor-β-induced myoepithelial marker that enhances invasion and correlates with poor prognosis in breast cancer | Fan L.-C.; YUNG-MING JENG ; Lu Y.-T.; HUANG-CHUN LIEN | PLoS ONE | 27 | 26 | |
19 | 2016 | PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer | Juang Y.-L.; YUNG-MING JENG ; Chen C.-L.; HUANG-CHUN LIEN | Molecular Carcinogenesis | 26 | 22 | |
20 | 2015 | Phosphorylation of ezh2 at t416 by cdk2 contributes to the malignancy of triple negative breast cancers | Yang C.-C.; Labaff A.; Wei Y.; Nie L.; Xia W.; Huo L.; Yamaguchi H.; Hsu Y.-H.; Hsu J.L.; Liu D.; Lang J.; Du Y.; HUANG-CHUN LIEN ; Li L.-Y.; Deng R.; Chan L.-C.; Yao J.; Kleer C.G.; Hortobagyi G.N.; Hung M.-C. | American Journal of Translational Research | 40 | ||
21 | 2015 | Frequent alterations of HER2 through mutation, amplification, or overexpression in pleomorphic lobular carcinoma of the breast | HUANG-CHUN LIEN ; Chen Y.-L.; Juang Y.-L.; YUNG-MING JENG | Breast Cancer Research and Treatment | 40 | 39 | |
22 | 2014 | Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells | Lin J.-J.; CHIUN-SHENG HUANG ; Yu J.; Liao G.-S.; HUANG-CHUN LIEN ; Hung J.-T.; Lin R.-J.; Chou F.-P.; Yeh K.-T.; Yu A.L. | Breast Cancer Research | 38 | 31 | |
23 | 2014 | Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance | HUANG-CHUN LIEN ; Lee Y.-H.; YUNG-MING JENG ; CHING-HUNG LIN ; YEN-SHEN LU ; Yao Y.-T. | Histopathology | 33 | 28 | |
24 | 2013 | Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance | HUANG-CHUN LIEN ; Wang C.-C.; CHING-HUNG LIN ; YEN-SHEN LU ; CHIUN-SHENG HUANG ; Hsiao L.-P.; Yao Y.-T. | Human Pathology | 12 | 12 | |
25 | 2013 | CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer | SUNG-HSIN KUO ; Yang, Shi-Yi; HUANG-CHUN LIEN ; Chiao Lo ; CHING-HUNG LIN ; YEN-SHEN LU ; ANN-LII CHENG ; KING-JEN CHANG ; CHIUN-SHENG HUANG | BioMed Research International | 9 | 9 | |
26 | 2013 | Ubiquitin carboxy-terminal hydrolase L1 may be involved in the development of mammary phyllodes tumors | HUANG-CHUN LIEN ; Wang C.-C.; CHIUN-SHENG HUANG ; YA-WEN YANG ; WEN-HUNG KUO ; Yao Y.-T. | Virchows Archiv | 5 | 4 | |
27 | 2012 | Differential expression of moesin in breast cancers and its implication in epithelial-mesenchymal transition | Wang C.-C.; JAU-YU LIAU ; YEN-SHEN LU ; Chen J.-W.; Yao Y.-T.; HUANG-CHUN LIEN | Histopathology | 40 | 36 | |
28 | 2012 | Human herpesvirus 8-associated lymphoma mimicking cutaneous anaplastic large T-cell lymphoma in a patient with human immunodeficiency virus infection | Li M.-F.; Hsiao C.-H.; Chen Y.-L.; Huang W.-Y.; Lee Y.-H.; Huang H.-N.; HUANG-CHUN LIEN | Journal of Cutaneous Pathology | 14 | 12 | |
29 | 2010 | Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy | CHING-HUNG LIN ; HUANG-CHUN LIEN ; Hu F.-C.; YEN-SHEN LU ; SUNG-HSIN KUO ; Wu L.-C.; You S.-L.; ANN-LII CHENG ; KING-JEN CHANG ; CHIUN-SHENG HUANG | Journal of Zhejiang University: Science B | 8 | 11 | |
30 | 2010 | Prolonged survival of a patient with cervical intramedullary glioblastoma multiforme treated with total resection, radiation therapy, and temozolomide | Tseng H.-M.; LU-TING KUO ; HUANG-CHUN LIEN ; KAO-LANG LIU ; Liu M.-T.; CHAO YUAN HUANG | Anti-Cancer Drugs | 19 | 17 | |
31 | 2008 | Differential expression of glucocorticoid receptor in carcinomas of the human digestive system | HUANG-CHUN LIEN ; YEN-SHEN LU ; CHIA-TUNG SHUN ; Yao Y.-T.; Chang W.-C.; ANN-LII CHENG | Histopathology | 18 | 17 | |
32 | 2008 | Beta-catenin expression and mutation in adult and pediatric Wilms' tumors | Su M.-C.; Huang W.-C.; HUANG-CHUN LIEN | APMIS | 18 | 13 | |
33 | 2008 | The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers | CHIUN-SHENG HUANG ; SUNG-HSIN KUO ; HUANG-CHUN LIEN ; Yang S.-Y.; You S.-L.; Shen C.-Y.; CHING-HUNG LIN ; YEN-SHEN LU ; KING-JEN CHANG | Oncologist | 19 | 18 | |
34 | 2008 | Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients | SUNG-HSIN KUO ; HUANG-CHUN LIEN ; You S.-L.; YEN-SHEN LU ; CHING-HUNG LIN ; Chen T.-Z.; CHIUN-SHENG HUANG | Breast | 13 | 12 | |
35 | 2007 | Radio-guided sentinel lymph node biopsy using periareolar injection technique for patients with early breast cancer | RUOH-FANG YEN ; WEN-HUNG KUO ; HUANG-CHUN LIEN ; Chen, Tony Hsiu Hsi ; I-SHIOW JAN ; YEN-WEN WU ; Wang, Ming Yang; KING-JEN CHANG ; CHIUN-SHENG HUANG | Journal of the Formosan Medical Association | 7 | 6 | |
36 | 2007 | Coexisting sclerosing angiomatoid nodular transformation of the spleen with multiple calcifying fibrous pseudotumors in a patient | JEN-CHIEH LEE ; HUANG-CHUN LIEN ; Hsiao C.-H. | Journal of the Formosan Medical Association | 39 | 31 | |
37 | 2006 | Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity | YEN-SHEN LU ; HUANG-CHUN LIEN ; Yeh P.-Y.; SUNG-HSIN KUO ; Chang W.-C.; Kuo M.-L.; ANN-LII CHENG | Lung Cancer | 35 | 34 | |
38 | 2006 | Levamisole-induced multifocal inflammatory leukoencephalopathy: Clinical characteristics, outcome, and impact of treatment in 31 patients | VIN-CENT WU ; JENQ-WEN HUANG ; HUANG-CHUN LIEN ; SUNG-TSANG HSIEH ; HON-MAN LIU ; Yang C.-C.; YEN-HUNG LIN ; HWANG, JUEY-JEN ; KWAN-DUN WU | Medicine | 45 | 35 | |
39 | 2006 | Epidemiological analysis of factors influencing an episode of exertional rhabdomyolysis in high school students | Lin H.; WEI-CHU CHIE ; HUANG-CHUN LIEN | American Journal of Sports Medicine | 28 | 22 | |
40 | 2006 | Primary brain T-cell lymphoma after kidney transplantation: a case report | Su I.-C.; HUANG-CHUN LIEN ; CHANG-MU CHEN | Surgical Neurology | 13 | 9 | |
41 | 2005 | Absence of epidermal growth factor receptor exon 18-21 mutation in hepatocellular carcinoma | Su M.-C.; HUANG-CHUN LIEN ; YUNG-MING JENG | Cancer Letters | 48 | 48 | |
42 | 2005 | Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors | YEN-SHEN LU ; HUANG-CHUN LIEN ; Yeh P.-Y.; KUN-HUEI YEH ; Kuo M.-L.; SUNG-HSIN KUO ; ANN-LII CHENG | World Journal of Gastroenterology | 26 | 25 | |
43 | 2004 | p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components | HUANG-CHUN LIEN ; CHUNG-WU LIN ; TSUI-LIEN MAO ; SUNG-HSIN KUO ; Hsiao C.-H.; CHIUN-SHENG HUANG | Journal of Pathology | 67 | 63 | |
44 | 2003 | Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer | BOR-CHING SHEU ; HUANG-CHUN LIEN ; HONG-NERNG HO ; HO-HSIUNG LIN ; SONG-NAN CHOW ; Huang S.-C; Hsu S.-M. | Cancer Research | 126 | 105 | |
45 | 2001 | Colonoscopic manifestations of primary colorectal lymphoma | Wang M.-H.; Wong J.-M.; HUANG-CHUN LIEN ; Lin C.-W.; Wang C.-Y. | Endoscopy | 22 | 25 | |
46 | 2001 | A novel role of metalloproteinase in cancer-mediated immunosuppression | BOR-CHING SHEU ; Hsu S.-M.; HONG-NERNG HO ; HUANG-CHUN LIEN ; Huang S.-C.; Lin R.-H. | Cancer Research | 261 | ||
47 | 2001 | Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer | BOR-CHING SHEU ; Lin R.-H.; HUANG-CHUN LIEN ; HONG-NERNG HO ; Hsu S.-M.; Huang S.-C. | Journal of Immunology | 176 | 156 | |
48 | 2000 | Metastatic carcinoma to the jugular foramen | Chao C.-K.; Sheen T.-S.; HUANG-CHUN LIEN ; Hsu M.-M. | Otolaryngology - Head and Neck Surgery | 8 | 5 | |
49 | 1999 | Merkel cell carcinoma and chronic arsenicism | HUANG-CHUN LIEN ; TSEN-FANG TSAI ; Yu Yun Lee, Hsiao C.-H. | Journal of the American Academy of Dermatology | 76 | 50 | |
50 | 1999 | Quiescent nasal T/NK cell lymphoma manifested as primary central nervous system lymphoma | KUN-HUEI YEH ; HUANG-CHUN LIEN ; Hsu S.-M.; ANN-LII CHENG | American Journal of Hematology | 31 | ||
51 | 1998 | Intermittent intussusception caused by colonic lipoma | Chan K.-C.; Lin N.-H.; HUANG-CHUN LIEN ; Chan S.-L.; Yu S.-C. | Journal of the Formosan Medical Association | 7 | 5 |